ALLIANCEBERNSTEIN L.P. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$96,000
-47.8%
34,600
+0.3%
0.00%
Q4 2021$184,000
-37.0%
34,5000.0%0.00%
Q3 2021$292,000
-30.6%
34,5000.0%0.00%
Q2 2021$421,000
+16.6%
34,500
+131.5%
0.00%
Q1 2021$361,000
-24.5%
14,9000.0%0.00%
Q4 2020$478,000
+10.6%
14,900
+4.2%
0.00%
Q3 2020$432,000
-32.2%
14,300
-5.3%
0.00%
Q2 2020$637,000
+186.9%
15,100
+69.7%
0.00%
Q1 2020$222,0008,9000.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders